SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,622,430 | -57.7% | 176,017 | -3.3% | 0.07% | -54.7% |
| Q2 2023 | $8,557,076 | +9.1% | 181,988 | -2.7% | 0.15% | -7.5% |
| Q1 2023 | $7,845,891 | +19.8% | 186,985 | +8.9% | 0.16% | +11.9% |
| Q4 2022 | $6,551,727 | -0.9% | 171,781 | +1.8% | 0.14% | -5.9% |
| Q3 2022 | $6,609,000 | +17.3% | 168,766 | -3.2% | 0.15% | +23.6% |
| Q2 2022 | $5,633,000 | -3.8% | 174,398 | -1.4% | 0.12% | +18.3% |
| Q1 2022 | $5,857,000 | -23.0% | 176,949 | -1.1% | 0.10% | -20.6% |
| Q4 2021 | $7,610,000 | -3.6% | 178,892 | +0.4% | 0.13% | -10.3% |
| Q3 2021 | $7,898,000 | +78.3% | 178,241 | +128.6% | 0.15% | +82.5% |
| Q2 2021 | $4,430,000 | -23.1% | 77,973 | +1.3% | 0.08% | -27.3% |
| Q1 2021 | $5,764,000 | -21.3% | 77,005 | -9.1% | 0.11% | -26.2% |
| Q4 2020 | $7,326,000 | +32.7% | 84,685 | -6.2% | 0.15% | +13.7% |
| Q3 2020 | $5,520,000 | +41.1% | 90,320 | -4.0% | 0.13% | +36.5% |
| Q2 2020 | $3,911,000 | – | 94,060 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |